178 related articles for article (PubMed ID: 22000381)
21. Human parvovirus B19 antibodies induce altered membrane protein expression and apoptosis of BeWo trophoblasts.
Tzang BS; Chiang SY; Chan HC; Liu CH; Hsu TC
Mol Med Rep; 2016 Nov; 14(5):4399-4406. PubMed ID: 27748859
[TBL] [Abstract][Full Text] [Related]
22. Long term follow up of serostatus after maternofetal parvovirus B19 infection.
Dembinski J; Eis-Hübinger AM; Maar J; Schild R; Bartmann P
Arch Dis Child; 2003 Mar; 88(3):219-21. PubMed ID: 12598382
[TBL] [Abstract][Full Text] [Related]
23. [Parvovirus B19 infection in pregnancy: a cause of non-immune hydrops fetalis].
Reintjes R; Bosman A; Buitenwerf J
Ned Tijdschr Geneeskd; 1999 Mar; 143(10):542. PubMed ID: 10321269
[No Abstract] [Full Text] [Related]
24. Atypical intrauterine parvo b19 infection.
Drašković B; Uram-Benka A; Fabri I; Velisavljev Filipović G
Med Glas (Zenica); 2012 Aug; 9(2):427-9. PubMed ID: 22926394
[TBL] [Abstract][Full Text] [Related]
25. Maternal-fetal transmission of human parvovirus B19 genotype 3.
Candotti D; Danso K; Parsyan A; Dompreh A; Allain JP
J Infect Dis; 2006 Sep; 194(5):608-11. PubMed ID: 16897659
[TBL] [Abstract][Full Text] [Related]
26. [Fetal death in hydrops fetalis at 21 weeks of amenorrhea].
Bellagra N; Hober D; Dewilde A; Bérard J; Subtil D; Wattré P
Ann Biol Clin (Paris); 1997; 55(5):470-1. PubMed ID: 9347016
[No Abstract] [Full Text] [Related]
27. Atypical manifestations of congenital parvovirus B19 infection.
Savarese I; De Carolis MP; Costa S; De Rosa G; De Carolis S; Lacerenza S; Romagnoli C
Eur J Pediatr; 2008 Dec; 167(12):1463-6. PubMed ID: 18309518
[TBL] [Abstract][Full Text] [Related]
28. Occurrence of human bocaviruses and parvovirus 4 in solid tissues.
Norja P; Hedman L; Kantola K; Kemppainen K; Suvilehto J; Pitkäranta A; Aaltonen LM; Seppänen M; Hedman K; Söderlund-Venermo M
J Med Virol; 2012 Aug; 84(8):1267-73. PubMed ID: 22711355
[TBL] [Abstract][Full Text] [Related]
29. [Parvovirus B19 infection--a risk factor during pregnancy. Asymptomatic course of disease makes the prevention and treatment more difficult].
Broliden K
Lakartidningen; 2003 Jan; 100(4):222-4. PubMed ID: 12580007
[No Abstract] [Full Text] [Related]
30. [Which supervision and treatment to use in case of exposure to Parvovirus B19 during pregnancy?].
Brochot C; Debever P; Subtil D; Puech F
Gynecol Obstet Fertil; 2008 Feb; 36(2):204-211. PubMed ID: 18262817
[TBL] [Abstract][Full Text] [Related]
31. Postnatal IVIG treatment for persistent anaemia in neonate due to congenital parvovirus infection.
Janssen O; Lin J
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33431449
[TBL] [Abstract][Full Text] [Related]
32. Parvovirus B19 infection.
Tolfvenstam T; Broliden K
Semin Fetal Neonatal Med; 2009 Aug; 14(4):218-21. PubMed ID: 19231308
[TBL] [Abstract][Full Text] [Related]
33. Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women.
Hemauer A; Gigler A; Searle K; Beckenlehner K; Raab U; Broliden K; Wolf H; Enders G; Modrow S
J Med Virol; 2000 Jan; 60(1):48-55. PubMed ID: 10568763
[TBL] [Abstract][Full Text] [Related]
34. Serologic study of human parvovirus B19 infection in pregnancy in Japan.
Yaegashi N; Niinuma T; Chisaka H; Uehara S; Okamura K; Shinkawa O; Tsunoda A; Moffatt S; Sugamura K; Yajima A
J Infect; 1999 Jan; 38(1):30-5. PubMed ID: 10090504
[TBL] [Abstract][Full Text] [Related]
35. Parvovirus PARV4 visualization and detection.
Tuke PW; Parry RP; Appleton H
J Gen Virol; 2010 Feb; 91(Pt 2):541-4. PubMed ID: 19846677
[TBL] [Abstract][Full Text] [Related]
36. [Anti-parvovirus B19 IgG antibody prevalence in pregnant women during antenatal follow-up and cases of non-immune hydropsis fetalis due to parvovirus B19, in the City of Rio de Janeiro].
da Silva AR; Nogueira SA; Alzeguir JC; da Costa MC; do Nascimento JP
Rev Soc Bras Med Trop; 2006; 39(5):467-72. PubMed ID: 17160325
[TBL] [Abstract][Full Text] [Related]
37. Risk of fetal hydrops and non-hydropic late intrauterine fetal death after gestational parvovirus B19 infection.
Enders M; Klingel K; Weidner A; Baisch C; Kandolf R; Schalasta G; Enders G
J Clin Virol; 2010 Nov; 49(3):163-8. PubMed ID: 20729141
[TBL] [Abstract][Full Text] [Related]
38. A clinical and epidemiological study of human parvovirus B19 infection in fetal hydrops using PCR Southern blot hybridization and chemiluminescence detection.
Wattre P; Dewilde A; Subtil D; Andreoletti L; Thirion V
J Med Virol; 1998 Feb; 54(2):140-4. PubMed ID: 9496373
[TBL] [Abstract][Full Text] [Related]
39. Human fetal infection with parvovirus B19: maternal infection time in gestation, viral persistence and fetal prognosis.
Nunoue T; Kusuhara K; Hara T
Pediatr Infect Dis J; 2002 Dec; 21(12):1133-6. PubMed ID: 12488663
[TBL] [Abstract][Full Text] [Related]
40. Parvovirus B19 infection in pregnancy studied by maternal viral load and immune responses.
de Haan TR; Beersma MF; Claas EC; Oepkes D; Kroes AC; Walther FJ
Fetal Diagn Ther; 2007; 22(1):55-62. PubMed ID: 17003557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
